Cytokinetics Inc (CYTK)

Debt-to-capital ratio

		Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Long-term debt	US$ in thousands	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Total stockholders’ equity	US$ in thousands	-135,372	-13,911	108,550	-396,160	-386,323	-438,801	-333,115	-229,020	-107,900	-15,977	111,414	116,261	243,863	249,020	16,489	67,846	113,383	149,605	-78,080	-45,711
Debt-to-capital ratio		—	—	0.00	—	—	—	—	—	—	—	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	—	—

December 31, 2024 calculation

Debt-to-capital ratio = Long-term debt ÷ (Long-term debt + Total stockholders’ equity)
= $—K ÷ ($—K + $-135,372K)
= —

Cytokinetics Inc's debt-to-capital ratio provides insight into the company's capital structure and financial leverage. The ratio is calculated by dividing the total debt by the sum of total debt and total equity, expressed as a percentage.

Based on the provided data, the debt-to-capital ratio for Cytokinetics Inc has remained consistently low throughout the reported periods. From September 30, 2020, to June 30, 2024, the ratio remained at 0.00, indicating that the company has been operating with minimal debt relative to its total capital.

A debt-to-capital ratio of 0.00 suggests that the company has either no debt or a very insignificant amount of debt in relation to its equity. This can be viewed positively by investors and creditors as it signifies lower financial risk and greater financial stability. Additionally, having a low debt-to-capital ratio may indicate that the company has more flexibility in managing its operations and expansions, as it is not heavily reliant on debt financing.

However, it is important to note that a consistently low debt-to-capital ratio may also imply that the company is not taking advantage of debt financing to potentially enhance returns on equity. While low debt levels are generally beneficial, it is essential for companies to strike a balance between debt and equity financing to optimize their capital structure and overall financial performance.